IDEAS home Printed from https://ideas.repec.org/p/hal/journl/hal-01345867.html
   My bibliography  Save this paper

Behind the success of the Brazilian anti-aids program, the indian industrial performance in pharmaceuticals
[Derrière le succès du programme antisida brésilien, les performances industrielles indiennes en pharmacie]

Author

Listed:
  • Samira Guennif

    (CEPN - Centre d'Economie de l'Université Paris Nord (ancienne affiliation) - UP13 - Université Paris 13 - CNRS - Centre National de la Recherche Scientifique)

Abstract

The Brazilian free and universal access program to anti-AIDS drugs has been described as a model whose replication in the developing world is largely discussed. According to the literature, this success of this program is related to the Brazilian capacity to bargain price reductions with patent holders, built on a constant threat to resort to compulsory license and the very existence of national capabilities in the pharmaceutical production. This paper shows that the successful scaling-up of the Brazilian anti-AIDS program owes a lot to the success of India in the pharmaceutical sector. Indeed, the Brazilian threat to resort to compulsory license has more to do with the tough competition exerted by Indian firms endowed with large industrial capabilities on the antiretroviral market than the limited industrial performances of Brazilian firms. Thus, the replication of this model in developing countries is questioned, especially for those deprived of industrial capabilities in pharmaceuticals.

Suggested Citation

  • Samira Guennif, 2012. "Behind the success of the Brazilian anti-aids program, the indian industrial performance in pharmaceuticals [Derrière le succès du programme antisida brésilien, les performances industrielles indie," Post-Print hal-01345867, HAL.
    • Handle: RePEc:hal:journl:hal-01345867
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hal:journl:hal-01345867. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: CCSD (email available below). General contact details of provider: https://hal.archives-ouvertes.fr/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.